Telbivudine Therapy in HBeAg-positive Pregnant Women to Prevent Mother-to-infant Transmission of HBV

This study is currently recruiting participants.
Verified August 2012 by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Sponsor:
Collaborator:
Taixing People's Hospital
Information provided by (Responsible Party):
Yi-Hua Zhou, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
ClinicalTrials.gov Identifier:
NCT01637844
First received: July 4, 2012
Last updated: August 5, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2014
  Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)